Flash FinanceUS
Market closed S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · Core Laboratories Inc. /DE/ (CLB)

Core Lab Q2 revenue falls 4% to $124.6 million; GAAP EPS $0.13

Mixed Impact 3 of 5 earnings Written later

Core Laboratories reported second-quarter 2026 revenue of $124.6 million, down 4% from a year earlier but up 2% from the first quarter, and GAAP diluted EPS of $0.13 versus $0.22 a year earlier. The company expects third-quarter revenue of $128.5 million to $135.5 million and EPS of $0.12 to $0.20, and declared a $0.01 per share quarterly dividend.

Key points

  • Q2 2026 revenue $124.6 million, down 4% year-over-year and up 2% sequentially; GAAP operating income $9.2 million
  • GAAP diluted EPS $0.13 versus $0.22 in Q2 2025; EPS excluding specific items $0.11
  • Q3 2026 guidance: revenue $128.5 million to $135.5 million; EPS $0.12 to $0.20
  • Quarterly dividend of $0.01 per share, record date August 10, 2026, payable August 31, 2026

The filing

CompanyCore Laboratories Inc. /DE/ (CLB)
Form8-K, current report
Filed with the SECJul 29, 2026, 4:43 PM ET
Accession number0001193125-26-324101

Items reported: 2.02 Results of Operations7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 11:46 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on July 29, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.